PRECIGEN, INC. Increase (Decrease) in Due from Related Parties, Current
PRECIGEN, INC. (PGEN) reported Increase (Decrease) in Due from Related Parties, Current of -$54.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent · last filed 2023-03-06
- PRECIGEN, INC. increase (decrease) in due from related parties, current for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. increase (decrease) in due from related parties, current for the quarter ending 2022-09-30 was $1.00K, a 97.73% decline year-over-year.
- PRECIGEN, INC. increase (decrease) in due from related parties, current for the quarter ending 2022-06-30 was $3.00K, a 70.00% decline year-over-year.
- PRECIGEN, INC. increase (decrease) in due from related parties, current for the quarter ending 2022-03-31 was -$58.00K.
- PRECIGEN, INC. increase (decrease) in due from related parties, current for fiscal 2022 was -$54.00K, a 200.00% decline from fiscal 2021.
- PRECIGEN, INC. increase (decrease) in due from related parties, current for fiscal 2021 was $54.00K.
- PRECIGEN, INC. increase (decrease) in due from related parties, current for fiscal 2020 was -$258.00K.
- PRECIGEN, INC. increase (decrease) in due from related parties, current for fiscal 2019 was -$967.00K.
| Period end | Increase (Decrease) in Due from Related Parties, Current 3 month | Increase (Decrease) in Due from Related Parties, Current 6 month | Increase (Decrease) in Due from Related Parties, Current 9 month | Increase (Decrease) in Due from Related Parties, Current 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $1.00K derived: sum of 2 quarters · filed 2023-03-06 | $4.00K derived: sum of 3 quarters · filed 2023-03-06 | -$54.00K 10-K · filed 2023-03-06 |
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.00K derived: sum of 2 quarters · filed 2022-11-09 | -$54.00K 10-Q · filed 2022-11-09 | -$47.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2022-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$55.00K 10-Q · filed 2022-08-08 | -$48.00K derived: sum of 3 quarters · filed 2023-03-06 | -$4.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2022-03-31 | -$58.00K 10-Q · filed 2022-05-09 | -$51.00K derived: sum of 2 quarters · filed 2023-03-06 | -$7.00K derived: sum of 3 quarters · filed 2023-03-06 | $3.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $51.00K derived: sum of 2 quarters · filed 2023-03-06 | $61.00K derived: sum of 3 quarters · filed 2023-03-06 | $54.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $54.00K derived: sum of 2 quarters · filed 2022-11-09 | $47.00K 10-Q · filed 2022-11-09 | $54.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.00K 10-Q · filed 2022-08-08 | $10.00K derived: sum of 3 quarters · filed 2023-03-06 | -$272.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | -$282.00K derived: sum of 3 quarters · filed 2023-03-06 | -$240.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$275.00K derived: sum of 2 quarters · filed 2023-03-06 | -$233.00K derived: sum of 3 quarters · filed 2023-03-06 | -$258.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | -$282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$240.00K derived: sum of 2 quarters · filed 2021-11-08 | -$265.00K 10-Q · filed 2021-11-08 | -$42.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $17.00K 10-Q · filed 2021-08-09 | $240.00K derived: sum of 3 quarters · filed 2022-03-01 | -$4.27M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$25.00K 10-Q · filed 2021-05-10 | $198.00K derived: sum of 2 quarters · filed 2022-03-01 | -$4.31M derived: sum of 3 quarters · filed 2022-03-01 | $592.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$4.28M derived: sum of 2 quarters · filed 2022-03-01 | $617.00K derived: sum of 3 quarters · filed 2022-03-01 | -$967.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $394.00K derived: sum of 2 quarters · filed 2020-11-09 | -$1.19M 10-Q · filed 2020-11-09 | -$6.11M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $3.32M 10-Q · filed 2020-08-10 | -$1.60M derived: sum of 3 quarters · filed 2021-03-01 | -$1.41M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$1.58M 10-Q · filed 2020-05-11 | -$6.50M derived: sum of 2 quarters · filed 2021-03-01 | -$6.31M derived: sum of 3 quarters · filed 2021-03-01 | -$7.86M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$4.72M derived: sum of 2 quarters · filed 2021-03-01 | -$6.27M derived: sum of 3 quarters · filed 2021-03-01 | -$11.00M 10-K · filed 2021-03-01 |
| 2018-09-30 | $194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.36M derived: sum of 2 quarters · filed 2019-11-12 | -$6.08M 10-Q · filed 2019-11-12 | -$7.79M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$6.28M 10-Q · filed 2019-08-09 | -$7.98M derived: sum of 3 quarters · filed 2020-03-02 | -$8.85M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$4.73M 10-Q · filed 2019-05-09 | -$6.43M derived: sum of 2 quarters · filed 2020-03-02 | -$7.29M derived: sum of 3 quarters · filed 2020-03-02 | -$10.35M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$2.57M derived: sum of 2 quarters · filed 2020-03-02 | -$5.63M derived: sum of 3 quarters · filed 2020-03-02 | -$631.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | -$862.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$3.92M derived: sum of 2 quarters · filed 2018-11-08 | $1.07M 10-Q · filed 2018-11-08 | $1.71M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$3.06M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | $1.94M 10-Q · filed 2018-08-13 | $2.57M derived: sum of 3 quarters · filed 2019-03-01 | $4.33M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $4.99M 10-Q/A · filed 2018-08-13 | $5.63M derived: sum of 2 quarters · filed 2019-03-01 | $7.39M derived: sum of 3 quarters · filed 2019-03-01 | $5.77M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $634.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.40M derived: sum of 2 quarters · filed 2019-03-01 | $774.00K derived: sum of 3 quarters · filed 2019-03-01 | -$6.80M 10-K · filed 2019-03-01 |
| 2016-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $140.00K derived: sum of 2 quarters · filed 2017-11-09 | -$7.44M 10-Q · filed 2017-11-09 | -$7.58M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$9.20M 10-Q · filed 2017-08-09 | -$9.34M derived: sum of 3 quarters · filed 2018-03-01 | $2.05M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$7.58M 10-Q · filed 2017-05-10 | -$7.72M derived: sum of 2 quarters · filed 2018-03-01 | $3.68M derived: sum of 3 quarters · filed 2018-03-01 | $6.27M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $11.26M derived: sum of 2 quarters · filed 2018-03-01 | $13.85M derived: sum of 3 quarters · filed 2018-03-01 | $11.04M 10-K · filed 2018-03-01 |
| 2015-09-30 | $11.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $13.99M derived: sum of 2 quarters · filed 2016-11-09 | $11.18M 10-Q · filed 2016-11-09 | $12.13M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$213.00K 10-Q · filed 2016-08-09 | $736.00K derived: sum of 3 quarters · filed 2017-03-01 | $2.88M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$2.81M 10-Q · filed 2016-05-10 | -$1.86M derived: sum of 2 quarters · filed 2017-03-01 | $291.00K derived: sum of 3 quarters · filed 2017-03-01 | $2.55M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.10M derived: sum of 2 quarters · filed 2017-03-01 | $5.36M derived: sum of 3 quarters · filed 2017-03-01 | $6.12M 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $4.41M derived: sum of 2 quarters · filed 2015-11-09 | $5.17M 10-Q · filed 2015-11-09 | $5.93M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $3.02M 10-Q · filed 2015-08-10 | $3.78M derived: sum of 3 quarters · filed 2016-02-29 | $7.50M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $759.00K 10-Q · filed 2015-05-11 | $1.52M derived: sum of 2 quarters · filed 2016-02-29 | $5.24M derived: sum of 3 quarters · filed 2016-02-29 | $2.50M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $760.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $4.48M derived: sum of 2 quarters · filed 2016-02-29 | $1.74M derived: sum of 3 quarters · filed 2016-02-29 | $4.97M 10-K · filed 2016-02-29 |
| 2013-09-30 | $3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $984.00K derived: sum of 2 quarters · filed 2014-11-13 | $4.21M 10-Q · filed 2014-11-13 | $4.34M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $489.00K 10-Q · filed 2014-08-14 | $622.00K derived: sum of 3 quarters · filed 2015-03-02 | $322.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $3.22M 10-Q · filed 2014-05-09 | $3.36M derived: sum of 2 quarters · filed 2015-03-02 | $3.06M derived: sum of 3 quarters · filed 2015-03-02 | |
| 2012-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$167.00K derived: sum of 2 quarters · filed 2015-03-02 | $93.00K 10-K · filed 2015-03-02 | |
| 2012-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | -$40.00K 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $260.00K 10-Q/A · filed 2013-10-21 | |||
| 2011-12-31 | $239.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |